| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.012 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |